Carter's, Inc. CRI | NYSE

$33.34 $0.29 | 0.88%

After Hours
$34.49 $1.15 | 3.45%

Company Overview:

Market Cap: $1.21B
PE Ratio: 7.39
52-Week Range: $32.04 - $72.11
Dividend Yield (FWD): 9.60% ($3.20)

10 Year Performance Metrics:

Total Return (with DRIP): -58.26% (-8.37% / yr)
Total Return (no DRIP): -49.00% (-6.51% / yr)
Share Price: -66.97%
Dividend Increase: 263.64
CRI 10-yr Total Return ($10K invested)
1Y 2Y 5Y 10Y All

CRI Dividend Payments, Yield & Share Price charts

Dividend Payments & Yield
CRI Dividend CAGR:1Y: 0.00%2Y: 3.28%5Y: 9.86%10Y: 15.46%
Share Price
CRI Price CAGR:1Y: -51.26%2Y: -29.91%5Y: -14.99%10Y: -10.42%

Unlock All Reports & Research Dividend Stocks like a BOSS!

Monthly
$15/mo
14-days Free Trial.
Unlimited Access to dividend stocks reports & multiple metrics, for Dividend-oriented Investors.
Visual Stock Research
Stock Comparison Tools
Dividend Stocks & ETFs
Revenue & EPS Estimates
Custom Dividend Reports
Start Free Trial
Yearly - 25% OFF
$135/yr
14-days Free Trial.
Unlimited Access to dividend stocks reports & multiple metrics, for Dividend-oriented Investors.
Visual Stock Research
Stock Comparison Tools
Dividend Stocks & ETFs
Revenue & EPS Estimates
Custom Dividend Reports
Start Free Trial

CRI Dividend Safety: Payout & Dividend to Free Cash Flow Ratios.

Dividend Payout Ratio - CRI
14-Day FREE Trial Get Full Access Now!
Dividend to Free Cash Flow Ratio - CRI
14-Day FREE Trial Get Full Access Now!

CRI Earnings, Revenue, Cash & Debt, Shares Outstaning:

CRI - EPS vs PE Ratio
14-Day FREE Trial Get Full Access Now!
CRI - FCF vs FCF / Share
14-Day FREE Trial Get Full Access Now!
CRI - EPS vs FCF / Share
14-Day FREE Trial Get Full Access Now!
CRI - FCF vs Stock Based Comp
14-Day FREE Trial Get Full Access Now!
CRI - Revenue vs Net Income
14-Day FREE Trial Get Full Access Now!
CRI - Cash & Debt
14-Day FREE Trial Get Full Access Now!
CRI - Revenue
14-Day FREE Trial Get Full Access Now!
CRI Revenue CAGR:1Y: -4.79%2Y: -4.86%5Y: -0.76%10Y: -0.83%
CRI - Earnings Per Share (EPS)
14-Day FREE Trial Get Full Access Now!
CRI EPS CAGR:1Y: -58.65%2Y: -32.72%5Y: 17.46%10Y: -7.52%
CRI - Net Income
14-Day FREE Trial Get Full Access Now!
CRI Net Income CAGR:1Y: -59.14%2Y: -34.30%5Y: 17.05%10Y: -10.79%
CRI - EBITDA
14-Day FREE Trial Get Full Access Now!
CRI EBITDA CAGR:1Y: -59.63%2Y: -40.22%5Y: 30.01%10Y: -12.56%
CRI - Free Cash Flow
14-Day FREE Trial Get Full Access Now!
CRI Free Cash Flow CAGR:1Y: 57.02%2Y: N/A5Y: 21.40%10Y: N/A
CRI - Free Cash Flow / Share
14-Day FREE Trial Get Full Access Now!
CRI Free Cash Flow / Share CAGR:1Y: 59.51%2Y: N/A5Y: 26.50%10Y: N/A
CRI - Gross Profit
14-Day FREE Trial Get Full Access Now!
CRI Gross Profit CAGR:1Y: -7.65%2Y: -3.01%5Y: 4.98%10Y: 0.25%
CRI - Expenses
14-Day FREE Trial Get Full Access Now!
CRI Expenses CAGR:1Y: -13.91%2Y: -13.50%5Y: 5.10%10Y: -6.73%
CRI - Shares Outstanding
14-Day FREE Trial Get Full Access Now!
CRI Shares Outstanding CAGR:1Y: -1.57%2Y: -2.47%5Y: -4.03%10Y: -3.91%
CRI - Share Buybacks
14-Day FREE Trial Get Full Access Now!
CRI Share Buybacks CAGR:1Y: -100.00%2Y: -100.00%5Y: -100.00%10Y: -100.00%
CRI - Stock-Based Comp
14-Day FREE Trial Get Full Access Now!
CRI Stock-Based Comp CAGR:1Y: 88.65%2Y: 49.86%5Y: 38.05%10Y: 7.48%
CRI - Dividends
14-Day FREE Trial Get Full Access Now!
CRI Dividend CAGR:1Y: 0.00%2Y: 3.28%5Y: 9.86%10Y: 15.46%
CRI - Revenue by Segment
14-Day FREE Trial Get Full Access Now!
CRI Revenue CAGR:1Y: -4.79%2Y: -4.86%5Y: -0.76%10Y: -0.83%
CRI - Revenue by Region
14-Day FREE Trial Get Full Access Now!
CRI Revenue CAGR:1Y: -4.79%2Y: -4.86%5Y: -0.76%10Y: -0.83%

Revenue, EPS, Net Income & Ebitda - Estimates VS Actual:

CRI - REVENUE: Actual + Estimates
14-Day FREE Trial Get Full Access Now!
CRI Actual Revenue CAGR:1Y: -4.79%2Y: -4.86%5Y: -0.76%10Y: -0.83%
CRI - EPS: Actual + Estimates
14-Day FREE Trial Get Full Access Now!
CRI Actual EPS CAGR:1Y: -58.65%2Y: -32.72%5Y: 17.46%10Y: -7.52%
CRI - NET INCOME: Actual + Estimates
14-Day FREE Trial Get Full Access Now!
CRI Actual Net Income CAGR:1Y: -59.14%2Y: -34.30%5Y: 17.05%10Y: -10.79%
CRI - EBITDA: Actual + Estimates
14-Day FREE Trial Get Full Access Now!
CRI Actual EBITDA CAGR:1Y: -59.63%2Y: -40.22%5Y: 30.01%10Y: -12.56%

Ratios, Profit Margins & Return on Capital:

CRI - Net Profit Margin
14-Day FREE Trial Get Full Access Now!
CRI Net Profit Margin CAGR:1Y: -57.04%2Y: -30.88%5Y: 17.14%10Y: -10.03%
CRI - Gross Profit Margin
14-Day FREE Trial Get Full Access Now!
CRI Gross Profit Margin CAGR:1Y: -3.00%2Y: 1.95%5Y: 5.79%10Y: 1.09%
CRI - Price to Earnings
14-Day FREE Trial Get Full Access Now!
CRI - Price To Sales Ratio
14-Day FREE Trial Get Full Access Now!
CRI - Return on Capital Employed
14-Day FREE Trial Get Full Access Now!
CRI - Return on Invested Capital
14-Day FREE Trial Get Full Access Now!

Compare stocks side-by-side
 

CRI Dividends Info:

Annual Dividend: $3.20
Forward Yield: 9.6%
Ex-Dividend Date: 2025-03-10
Lifetime Dividens / Share: $20.72

CRI Dividend History: Dates, Payments & Yield list

Below is a schedule of all CRI dividend payments, ex-dates, share price on the day of the payment as well as TTM & forward yield

Ex-Date Payment Date Amount TTM Yield Forward Yield Price on Ex-Date
03/10/202503/28/2025$0.8007.28%7.28%$43.96
11/25/202412/06/2024$0.8005.79%5.79%$55.28
08/27/202409/13/2024$0.8004.56%4.63%$69.13
05/24/202406/07/2024$0.8004.7%4.86%$65.91
03/08/202403/29/2024$0.8003.66%3.84%$83.25
11/27/202312/08/2023$0.7504.47%4.47%$67.08
08/29/202309/15/2023$0.7504.28%4.28%$70.16
05/26/202306/09/2023$0.7504.79%4.79%$62.60
03/06/202303/17/2023$0.7504.14%4.14%$72.54
11/28/202212/09/2022$0.7504.11%4.11%$72.99
09/01/202209/16/2022$0.7503.88%4.08%$73.50
05/27/202206/10/2022$0.7503.24%3.88%$77.24
03/07/202203/18/2022$0.7502.35%3.28%$91.58
11/30/202112/10/2021$0.6001.39%2.38%$101.03
08/30/202109/17/2021$0.4000.77%1.53%$104.44
05/11/202105/28/2021$0.4000.39%1.56%$102.58
03/05/202003/20/2020$0.6002.4%2.74%$87.50
12/02/201912/13/2019$0.5001.99%1.99%$100.62
08/30/201909/20/2019$0.5002.13%2.19%$91.48
05/28/201906/14/2019$0.5002.16%2.27%$87.98
03/11/201903/22/2019$0.5001.98%2.14%$93.26
11/26/201812/14/2018$0.4501.94%1.94%$92.62
08/24/201809/07/2018$0.4501.64%1.71%$105.13
05/25/201806/15/2018$0.4501.46%1.6%$112.42
03/09/201803/23/2018$0.4501.37%1.58%$114.12
11/17/201712/01/2017$0.3701.41%1.41%$105.07
08/25/201709/08/2017$0.3701.65%1.7%$87.03
05/25/201706/16/2017$0.3701.69%1.78%$83.04
03/08/201703/24/2017$0.3701.55%1.68%$87.86
11/17/201612/02/2016$0.3301.42%1.42%$93.16
08/26/201609/09/2016$0.3301.25%1.36%$96.73
05/19/201606/03/2016$0.3301.11%1.33%$99.26
03/09/201603/25/2016$0.3300.98%1.31%$100.76
11/19/201512/04/2015$0.2201.02%1.02%$86.36
08/28/201509/11/2015$0.2200.86%0.89%$98.54
05/19/201506/05/2015$0.2200.82%0.88%$100.48
03/06/201503/20/2015$0.2200.89%0.99%$88.83
11/21/201412/05/2014$0.1900.92%0.92%$82.18
08/28/201409/12/2014$0.1900.88%0.92%$82.73
05/27/201406/12/2014$0.1900.95%1.03%$73.91
03/06/201403/20/2014$0.1900.87%0.99%$77.13
11/26/201312/12/2013$0.1600.68%0.91%$70.62
08/29/201309/13/2013$0.1600.45%0.9%$71.00
05/29/201306/14/2013$0.1600.23%0.91%$70.67

Projected Future Returns & Dividends for CRI

Based on past 10-year performance, here are CRI growth metrics:

Share price CAGR of -10.42%
Dividend CAGR of +13.78%

Using CRI CAGR metrics, we can estimate that your initial $10000 investment, over the next 10 years, should grow as follows:

CRI (DRIP)CRI - No DRIP
Current Price$33.34$33.34
Start Shares299.94299.94
Start Value$10,000$10,000
  
After 10 years:
Final Share Count8,336.66299.94
Dividends Payment$2.91$2.91
Annual Dividends$97,008$3,490
Yield on cost970.08%34.90%
Share Price$12.39$12.39
Total Dividends$112,922$18,363
Final Value$103,267$22,078

Estimated Future Value + Dividends - CRI

NOTE: Above numbers are our estimate based on CRI's Dividend and Price CAGR over past 10 years. These numbers should only be considered as "potential future returns"! DRIP assumes reinvesting dividends; No-DRIP assumes collecting dividends as cash.

We cannot guarantee that your actual returns will meet these estimates.

Get the best Dividend Stock Research Tools:

Monthly
$15/mo
14-days Free Trial.
Unlimited Access to dividend stocks reports & multiple metrics, for Dividend-oriented Investors.
Visual Stock Research
Stock Comparison Tools
Dividend Stocks & ETFs
Revenue & EPS Estimates
Custom Dividend Reports
Start Free Trial
Yearly - 25% OFF
$135/yr
14-days Free Trial.
Unlimited Access to dividend stocks reports & multiple metrics, for Dividend-oriented Investors.
Visual Stock Research
Stock Comparison Tools
Dividend Stocks & ETFs
Revenue & EPS Estimates
Custom Dividend Reports
Start Free Trial

Company Info

Carter's, Inc. (CRI) had its IPO on 2003-10-28, and is trader on NYSE stock exchange.

Carter's, Inc., together with its subsidiaries, designs, sources, and markets branded childrenswear under the Carter's, OshKosh, Skip Hop, Child of Mine, Just One You, Simple Joys, Carter's My First Love, little planet, and other brands in the United States and internationally. The company operates through three segments: U.S. Retail, U.S. Wholesale, and International. Its Carter's products include babies and young children products, such as bodysuits, pants, dresses, knit sets, blankets, layette essentials, bibs, booties, sleep and play products, rompers, and jumpers; and OshKosh brand products comprise playclothes, such as denim apparel products with multiple wash treatments and coordinating garments, overalls, woven bottoms, knit tops, and bodysuits. The company also provides products for playtime, travel, mealtime, bathtime, and homegear, as well as kid's bags and diaper bags under the Skip Hop brand. In addition, it offers bedding, cribs, diaper bags, footwear, gift sets, hair accessories, jewelry, outerwear, paper goods, socks, shoes, swimwear, and toys. The company operates 18,800 wholesale locations, including department stores, national chain stores, and specialty stores. As of December 31, 2021, it operated 980 retail stores. The company also sells its products through its eCommerce websites, such as carters.com, oshkoshbgosh.com, oshkosh.com, and skiphop.com, as well as other international wholesale accounts and licensees. Carter's, Inc. was founded in 1865 and is headquartered in Atlanta, Georgia.

CRI website: https://www.carters.com


Get Full Access to All Reports with DRIPCalc PRO

Monthly
$15/mo
14-days Free Trial.
Unlimited Access to dividend stocks reports & multiple metrics, for Dividend-oriented Investors.
Visual Stock Research
Stock Comparison Tools
Dividend Stocks & ETFs
Revenue & EPS Estimates
Custom Dividend Reports
Start Free Trial
Yearly - 25% OFF
$135/yr
14-days Free Trial.
Unlimited Access to dividend stocks reports & multiple metrics, for Dividend-oriented Investors.
Visual Stock Research
Stock Comparison Tools
Dividend Stocks & ETFs
Revenue & EPS Estimates
Custom Dividend Reports
Start Free Trial